NURAMAL

This brand name is authorized in Nigeria.

Active ingredients

The drug NURAMAL contains one active pharmaceutical ingredient (API):

1	Artemether UNII C7D6T3H22J - ARTEMETHER
	Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
	Read more about Artemether

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100569	Injection	NURAMAL 80 INJECTION INJ 80 mg 6 X 1ML	63 NF-PP-326522 NURAMAL 80 INJECTION ARTEMETHER 80mg/ml ARTEMETHER 80MG, BENZYL ALCOHOL BP 1%WW, ARACHIS OIL BP- QS A4-100569 Drugs Imported Products 61ML POM 1 4/26/2023 AL-SAMPARDA PHARMACEUTICALS NIGERIA LIMITED, NO 24, ABUJA ROAD SABO-TASHA KADUNA KADUNA KADUNA 8038540440 alsampardapharm@outlook.com FARBE FIRMA PRIVATE LIMITED, Plot No, 1508, GIDC, ANKLESHWAR 393002, GUJARAT, India	31/10/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BE02	Artemether	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BE Artemisinin and derivatives
Discover more medicines within P01BE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100569